Provided by Tiger Fintech (Singapore) Pte. Ltd.

Lipocine

3.31
+0.05001.53%
Post-market: 3.23-0.0800-2.42%17:21 EDT
Volume:9.50K
Turnover:31.68K
Market Cap:17.71M
PE:-2.04K
High:3.49
Open:3.49
Low:3.18
Close:3.26
Loading ...

Lipocine Inc. Reports 2024 Financial Turnaround

TIPRANKS
·
04 Apr

BRIEF-Lipocine Announces Initiation of Outpatient Phase 3 Postpartum Depression Trial of LPCN 1154

Reuters
·
26 Mar

Lipocine Inc: Patient Dosing Expected in Q2/2025

THOMSON REUTERS
·
26 Mar

Lipocine Announces Initiation of Outpatient Phase 3 Postpartum Depression Trial of Lpcn 1154

THOMSON REUTERS
·
26 Mar

Lipocine Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
13 Mar

Lipocine FY24 Sales $11.198M Beat $10.321M Estimate

Benzinga
·
13 Mar

Press Release: Lipocine Announces Financial Results for the Full Year Ended December 31, 2024

Dow Jones
·
13 Mar

Lipocine Inc expected to post a loss of 40 cents a share - Earnings Preview

Reuters
·
03 Mar

Lipocine receives updated regulatory guidance on LPCN 1154

TIPRANKS
·
06 Feb

Lipocine Inc - FDA Requires Efficacy and Safety Study for Lpcn 1154 Nda Submission

THOMSON REUTERS
·
06 Feb

Lipocine Receives Updated Regulatory Guidance on Lpcn 1154

THOMSON REUTERS
·
06 Feb

Lipocine Inc - Plans Phase 3 Safety and Efficacy Study for Lpcn 1154

THOMSON REUTERS
·
06 Feb

Lipocine Receives Updated Regulatory Guidance on LPCN 1154

PR Newswire
·
06 Feb

Lipocine Says LPCN 1148 Gets FDA Fast Track Label

MT Newswires Live
·
18 Dec 2024

FDA Grants Fast Track Designation to Lipocine for Lpcn 1148 as a Treatment for Sarcopenia in Patients With Decompensated Cirrhosis

THOMSON REUTERS
·
17 Dec 2024

FDA Grants Fast Track Designation to Lipocine for LPCN 1148 as a Treatment for Sarcopenia in Patients with Decompensated Cirrhosis

PR Newswire
·
17 Dec 2024

BRIEF-Lipocine Announces Publication And Discussion Of LPCN 1148 Manuscript At The Liver Meeting 2024 Editor's Cut Session

Reuters
·
18 Nov 2024

Lipocine announces publication, discussion of LPCN 1148

TIPRANKS
·
18 Nov 2024

Lipocine Announces Publication and Discussion of Lpcn 1148 Manuscript at the Liver Meeting 2024 Editor's Cut Session

THOMSON REUTERS
·
18 Nov 2024

Lipocine Announces Publication and Discussion of LPCN 1148 Manuscript at The Liver Meeting 2024 Editor's Cut Session

PR Newswire
·
18 Nov 2024